Juan Carlos
Montero González
Researcher from 2021
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublications in collaboration with researchers from Institut d'Investigació Biomédica de Bellvitge (1)
2019
-
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study
Breast Cancer Research and Treatment, Vol. 174, Núm. 3, pp. 693-701